Patents by Inventor Lingbo Zhang

Lingbo Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUSCARINIC ACETYLCHOLINE RECEPTOR SUBTYPE 4 ANTAGONISTS IN THE TREATMENT OF ANEMIA
    Publication number: 20220185821
    Abstract: This disclosure generally relates to treating anemias. More specifically, the disclosure relates to use of muscarinic acetylcholine receptor subtype 4 antagonists, such as small molecule compounds, to promote self-renewal of burst forming unit erythroid (BFU-E) cells and treat anemias.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 16, 2022
    Inventors: Yousef AL ABED, Lingbo ZHANG
  • COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA
    Publication number: 20200323898
    Abstract: The present disclosure relates generally to methods for ameliorating or treating acute myeloid leukemia (AML). In particular, the present technology relates to administering a therapeutically effective amount of one or more compositions that inhibit the vitamin B6 pathway to a subject diagnosed with, or at risk for AML.
    Type: Application
    Filed: November 27, 2018
    Publication date: October 15, 2020
    Inventors: Scott Lowe, Lingbo Zhang, Chichao Chen